Guided versus standard antiplatelet therapy in patients undergoing interventional intracranial aneurysm treatment using stents: protocol of a cluster randomized controlled cohort study.

This article discusses a cluster randomized controlled cohort study that aims to compare guided antiplatelet therapy with standard dual antiplatelet therapy (SDAT) in patients undergoing interventional intracranial aneurysm treatment using stents. The study will be conducted in eight hospitals in mainland China, with 590 patients enrolled. The primary outcome measure is the incidence of cerebral ischemic events within 30 days of stent placement, and the safety measure is all bleeding events within 30 days of treatment. The trial aims to determine whether guided antiplatelet therapy can reduce the incidence of ischemic events without increasing the risk of bleeding in these patients. [Extracted from the article]